KENNETH REAY CODE - 30 Sep 2023 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Chief Science Officer, Director
Signature
/s/ John R. Browning, Attorney-in-Fact
Issuer symbol
BLGO
Transactions as of
30 Sep 2023
Net transactions value
+$3,150
Form type
4
Filing time
03 Oct 2023, 18:20:26 UTC
Previous filing
05 Jul 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLGO Common stock Award $3,150 +19,010 +0.08% $0.1657 24,989,958 30 Sep 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share).
F2 Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.